期刊文献+

急性髓系白血病细胞表面同时表现淋系抗原的临床及免疫学分析 被引量:4

The clinical and immunological analysis of acute myelogenous leukemia who also have simul taneous lymphoid antigens expressied
原文传递
导出
摘要 目的探讨淋系抗原在急性髓系白血病细胞上的表达及意义。方法采用间接免疫荧光法检测182例急性髓系白血病细胞的免疫表型。根据FAB亚型和免疫标志将病例分为2组:伴淋系相关抗原的急性髓细胞性白血病(Ly+AML),不伴淋系相关抗原的急性髓细胞性白血病(Ly-AML)。结果182例AML中有64例表达淋系抗原(33%),CD+7在AML中表达率为54.7%,M0中阳性率最高100%,M1次之78%。Ly+AML组的白细胞、血小板数高于Ly-AML,有显著性差异。Ly+AML组与Ly-AML组的诱导缓解率及临床特征无显著性差异。Ly+AML组和Ly-AML组比较,平均缓解期较短。结论CD+7AML与AML蛳M0、M1有着密切的关系,可以看作是一个独特的临床亚型。Ly+AML较之Ly-AML具有不同的临床特征和短CR期。Ly+AML的出现可以作为危险因子中的一个因子来选择更合适的化疗也许是必要的。 Objective To explore the clinical significance of lymphoid antigens expression in acute myelogenous leukemia. Methods Immunophenotypes were examined using indireat immunofluoresence method in 182 patients with AML. All patients are classified into to groups cording to FAB subtypes and immunophenotyes: acute myeloid leukemia displaying lymphoid surface markers (Ly+AML),acute myeloid leukemia displaying no lymphoid surface markers(Ly-AML). Results The expression of lymphoid antigens in 182 cases of AML observed at our institution, 64 cases (33 %) carried lymphoid antigens. CD+7 35 cases (54.7 %). Incidence of CD+7 expression in each FAB subtype was also different. CD+7 expression were signficanty more frequent in AML- M0?M1 (100 %, 78 %, respectively). The typical characteristic in CD AML was CD34 high. The WBC and BPC count of Ly+AML patients are higher than Ly-AML patients have significant difference. The complete remission rate and clinical characteristics between Ly+AML patients and Ly-AML patients have no significant difference. The median remission duration of Ly+AML patients are relatively shorter than Ly-AML patients. Conclusions Thers was relationship between the CD+34 expression and FAB subtyes (M0, M1), it may present a particular subset of AML. Ly+AML are differ from Ly-AML on clinical characteristics and shorter CR durations. The appearance of Ly+AML indicates the patient had one of the high risk factors, so it is necessary to select individalzed chemotherapy protocol for them.
出处 《白血病.淋巴瘤》 CAS 2005年第1期14-16,共3页 Journal of Leukemia & Lymphoma
基金 新疆维吾尔自治区科技厅自然科学基金资助项目(200121102)
关键词 急性髓系白血病 淋系分化抗原 免疫表型 Acute myeloid leukemia Lymphoid differentiation antigen Immunophenotype
  • 相关文献

参考文献6

二级参考文献6

  • 1李建勇 薛永权 等.98例成人急性白血病形态学免疫学及细胞遗传学分型诊断[J].中华肿瘤杂志,1996,18:150-150.
  • 2陈珊珊,中华血液学杂志,1995年,16卷,17页
  • 3王德炳,北京医科大学学报,1993年,1卷,1页
  • 4钱林生,中华血液学杂志,1992年,13卷,7页
  • 5李建勇,中华肿瘤杂志,1996年,18期,150页
  • 6王德炳,邓星明,陈珊珊,丘镜滢,吴平娜,付剑锋,单福香,江滨,史琪,任汉云,刘素贤,陆道培.急性白血病形态学和免疫学及细胞遗传学分型分析[J].北京医科大学学报,1993,25(1):1-4. 被引量:12

共引文献97

同被引文献28

  • 1王兴兵,姚军霞,郑金娥,刘隽,李小青,贺艳丽,喻竞明,杨晶,魏君,刘仲萍,黄士昂.115例急性髓细胞白血病多参数流式细胞术免疫表型分析[J].中国实验血液学杂志,2005,13(2):250-253. 被引量:20
  • 2刘斌,李睿,吴辉菁,陈燕.急性白血病Ly+AML型和My+ALL型预后因素的临床研究[J].中国实验血液学杂志,2007,15(2):421-424. 被引量:25
  • 3肖志坚,郝玉书.免疫表型分析与急性白血病诊断[J].中华血液学杂志,1997,18(1):53-54. 被引量:67
  • 4张之南.血液病诊断及疗效标准[M].3版.北京:科学出版社,2008:1.
  • 5Bene MC,Castoldi G,Knapp W,et al. Proposals for the immunological classification of acute leukemias.European group for the immunological characterization of leukemias(EGIL)[J]. Leukemia, 1995,9(10): 1783-1786.
  • 6Bene MC,Bernier M,Casasnovas RO,et al.The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias.The European Group for the Immunological Classification of Leukemias(EGIL)[J].Blood,1998,92(2):596-599.
  • 7Casasnovas RO,Slimane FK,Garand R,et al.Immunological classification of acute myeloblastic leukemias:relevance to patient outcome[J].Leukemia,2003,17(3):515-527.
  • 8Paietta E.Expression of cell-surface antigens in acute promyelocytic leukaemia[J].Best Pract Res Clin Haematol,2003,16(3):369-385.
  • 9王蕊,温丙昭,钟笛,迪丽娜孜.阿不来提,李玲.交叉表达髓系和淋系相关抗原急性白血病的免疫学及临床特征研究[J].中国免疫学杂志,2007,23(11):1042-1043. 被引量:1
  • 10Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia [ J ]. Nat Rev Cancer, 2002, 2( 7 ) : 502-513.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部